Table 2.
Travelers taking malaria chemoprophylaxis (out of all travelers)
| Prophylaxis | No prophylaxis | P-value | |
|---|---|---|---|
| Total | 558 (11.9%) | 4,150 (88.1%) | |
| Gender (N = 4,708) | 558 | 4,150 | NS |
| Male: Female (%) | 12.1: 11.6 | 88.4: 87.9 | |
| Age (years) (N = 4,705) | 558 | 4,147 | |
| Mean (years) | 39 ± 15 | 36.5 ± 12 | 0.019 |
| Median (years) | 33 | 33 | |
| Travel duration* (N = 4,550) | 539 | 4,011 | |
| Mean (years) | 66 ± 79 | 58 ± 72 | NS |
| Median (years) | 30 | 24 | |
| Type of travel (N = 4,643) | 540 | 4,103 | |
| High-standard trips | 129 (7%) | 1,826 (93%) | |
| Backpackers | 259 (14%) | 1,557 (86%) | < 0.001 |
| Business/expatriates | 85 (14%) | 534 (86%) | |
| Organized trips | 50 (31%) | 111 (69%) | |
| Visiting friends and relatives | 6 (17%) | 29 (83%) |
NS = not significant.
* Not including 137 patients who spent more than 365 days abroad.